CBS
Cystathionine beta-synthase
Also known as: CBS_HUMAN, HIP4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35520
- Gene
- CBS
- Ensembl
- ENSG00000160200
- Chromosome
- 21
- Canonical length
- 551 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Vesicles
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
551 residues, UniProt reviewed canonical sequence.
>P35520|CBS
1 MPSETPQAEV GPTGCPHRSG PHSAKGSLEK GSPEDKEAKE PLWIRPDAPS RCTWQLGRPA
61 SESPHHHTAP AKSPKILPDI LKKIGDTPMV RINKIGKKFG LKCELLAKCE FFNAGGSVKD
121 RISLRMIEDA ERDGTLKPGD TIIEPTSGNT GIGLALAAAV RGYRCIIVMP EKMSSEKVDV
181 LRALGAEIVR TPTNARFDSP ESHVGVAWRL KNEIPNSHIL DQYRNASNPL AHYDTTADEI
241 LQQCDGKLDM LVASVGTGGT ITGIARKLKE KCPGCRIIGV DPEGSILAEP EELNQTEQTT
301 YEVEGIGYDF IPTVLDRTVV DKWFKSNDEE AFTFARMLIA QEGLLCGGSA GSTVAVAVKA
361 AQELQEGQRC VVILPDSVRN YMTKFLSDRW MLQKGFLKEE DLTEKKPWWW HLRVQELGLS
421 APLTVLPTIT CGHTIEILRE KGFDQAPVVD EAGVILGMVT LGNMLSSLLA GKVQPSDQVG
481 KVIYKQFKQI RLTDTLGRLS HILEMDHFAL VVHEQIQYHS TGKSSQRQMV FGVVTAIDLL
541 NFVAAQERDQ KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CBS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 177 nTPM
Expression across tissuesHPA
Tissue
- liver: 177 nTPM
- pancreas: 128 nTPM
- cerebellum: 53 nTPM
- cerebral cortex: 37 nTPM
- amygdala: 31 nTPM
- ovary: 30 nTPM
Single-cell type
- bergmann glia: 16 nCPM
- enterocytes: 5.3 nCPM
- epicardial cells: 4.5 nCPM
- astrocytes: 4.3 nCPM
- breast lactating cells: 4.3 nCPM
- peritubular myoid cells: 1.3 nCPM
Immune cell
- neutrophil: 6.5 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 113 nTPM
- thalamus: 83 nTPM
- white matter: 75 nTPM
- medulla oblongata: 73 nTPM
- midbrain: 71 nTPM
- amygdala: 67 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CBS.
Disease | AllUniProt
Conditions CBS is implicated in, by any mechanism.
- Cystathionine beta-synthase deficiency (CBSD) MIM:236200
Disease | GeneticClinVar
280 pathogenic / likely-pathogenic of 1,429 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Classic homocystinuria
- HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED
- Homocystinuria
- Familial thoracic aortic aneurysm and aortic dissection
- CBS-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.83
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood vessel diameter maintenance
- blood vessel remodeling
- cartilage development involved in endochondral bone morphogenesis
- cellular response to hypoxia
- cerebellum morphogenesis
- cysteine biosynthetic process
- cysteine biosynthetic process via cystathionine
- DNA protection
- endochondral ossification
- homocysteine catabolic process
- homocysteine metabolic process
- hydrogen sulfide biosynthetic process
- L-cysteine catabolic process
- L-serine catabolic process
- L-serine metabolic process
- maternal process involved in female pregnancy
- negative regulation of apoptotic process
- regulation of JNK cascade
- regulation of nitric oxide mediated signal transduction
- response to folic acid
- superoxide metabolic process
- transsulfuration
- cysteine biosynthetic process from serine
Molecular functions
- carbon monoxide binding
- enzyme binding
- heme binding
- identical protein binding
- metal ion binding
- modified amino acid binding
- nitric oxide binding
- oxygen binding
- protein homodimerization activity
- pyridoxal phosphate binding
- S-adenosyl-L-methionine binding
- ubiquitin protein ligase binding
- cystathionine beta-synthase activity
- nitrite reductase (NO-forming) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- CBS domain
- Tryptophan synthase beta chain-like, PALP domain
- Tryptophan synthase beta chain-like, PALP domain superfamily
- CBS domain superfamily
- Pyridoxal-phosphate dependent enzyme
- CBS domain
- Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site
- Cystathionine beta-synthase
- Cystathionine beta-synthase, C-terminal domain
- Cysteine synthase/Cystathionine beta-synthase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CBS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CBS as an antibody target. Whether an autoantibody or antibody against CBS could matter depends on whether native CBS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CBS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CBS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...